About Clinical Care
California’s hospitals are dedicated to providing high-quality, safe, and person-centered health care. This wouldn’t be possible without the clinical services hospitals provide, which include emergency care, surgery, X-ray/radiology, laboratory services, and behavioral health care. The care that hospitals provide is shaped by their communities’ needs.
Former patrol cop Diane Robinson is pursuing her dream of competing in a bodybuilding event following spine surgery.
Outwardly, Greigh seemed to be a healthy baby. But internally, he carried the gene of a catastrophic muscle disease.
The Food and Drug Administration (FDA) will hold a webinar at 10 a.m. (PT) on Oct. 31 to discuss its proposed rule for laboratory developed tests (LDTs).
Starting Aug. 1, 2024, all California dispensers of controlled substances will be required to report dispensations to the controlled substance utilization review and evaluation system (CURES) using version 4.2B of the American Society of Automation in Pharmacy (ASAP) format. On and after this date, data submitted using the current CURES ASAP version 4.1 format will no longer be accepted.
The Drug Enforcement Administration and the Substance Abuse and Mental Health Services Administration has extended its COVID-19 pandemic rules for prescribing controlled substances via telemedicine through Dec. 31, 2024. The regulation is effective Nov. 11.
The Food and Drug Administration (FDA) has published a proposed rule on the regulation of laboratory developed tests (LDTs). Comments on the proposed rule are due Dec. 4.
Born and raised in Cuba, Angelfrey Armas Ruiz, MD, made significant sacrifices on his path to becoming a doctor.
The Board of Pharmacy is warning licensees to be aware of scam callers claiming to represent the California State Board of Pharmacy or another government agency. In many cases, callers are attempting to extort money or elicit sensitive information — e.g., license numbers, DEA registration numbers, etc. — from licensees.
An experimental regenerative brain cell therapy could revolutionize the treatment of temporal lobe epilepsy.
On Aug. 17, the Department of Health Care Services (DHCS) and its Medi-Cal Rx contractor Magellan posted an updated provider bulletin notifying pharmacy providers of its plan to recommence pharmacy outpatient drug retroactive fee-for-service (FFS) claims adjustments with dates of service from May 2017 through February 2019.